SRRK

Scholar Rock Holding Corporation

Price

$56.51

return (12m)

87.62%

p/e

-16.80

p/bv

27.05

DIVIDEND YIELD

0.00%

SRRK price

Scholar Rock Holding

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SRRK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

10.46%

3 months

18.42%

1 year

87.62%

2 years

501.17%

5 years

46.40%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals SRRK

Valuation

P/E

-16.80

Sector -4.38

Industry -4.38

P/BV

27.05

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-62.51

Sector -263.09

Industry -263.09

EV/EBIT

-62.33

Sector -702.90

Industry -702.90

P/EBITDA

-17.32

Sector -4.39

Industry -4.39

P/EBIT

-17.25

Sector -4.73

Industry -4.73

P/Total Assets

13.11

Sector 1.49

Industry 1.49

P/Net Current Assets

28.91

Sector -11.70

Industry -11.70

P/Working Capital

15.78

Sector -3.19

Industry -3.19

EPS

-3.12

Sector -2.14

Industry -2.14

BVPS

1.94

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-161.01%

Sector -65.14%

Industry -65.14%

ROA

-78.05%

Sector -65.53%

Industry -65.53%

ROIC

-1,788.12%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

7.02

Sector 2.90

Industry 2.90

Net Debt / EBITDA

2.82

Sector -6.07

Industry -6.07

Net Debt / EBIT

2.81

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.17

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.77

Sector -0.05

Industry -0.05

Equity/Assets

0.48

Sector 0.41

Industry 0.41

Liabilities/Assets

0.52

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

25.39%

Sector -

Industry -

Fundamentals SRRK

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SRRK Scholar Rock Holding Corporation	$56.51	79.28%	0.00%	-16.80	27.05	-161.01%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SRRK Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Scholar Rock Holding

Scholar Rock Holding Corporation

Average Investor10 user rating

4.0 (0 people)

United States

9 years

Founded: 2017

2018

Time since IPO - 8 years

119

Employees

Scholar Rock Holding Corporation (United States) is listed on the Nasdaq and has a market capitalization of $6.86 billion, with shareholders equity totaling $253.78 million.

The company employs approximately 119 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Scholar Rock Holding Corporation reported $- in revenue, generating net income of $-408.60 million.

Key financial metrics include a P/E ratio of -16.80, a price-to-book (P/B) ratio of 27.05, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SRRK.

Market cap

$6.86 billion

Net worth

$253.78 million

$253,780,000.00

Assets

$523.54 million

$523,540,000.00

Total Shares Outstanding

131.00 million

131,000,000

Average Daily Trading Volume

$1.35 million

$1,352,660.00

Sector

Health Care

Industry

Biotechnology

SRRK

SRRK revenue and profits

Financial Results SRRK

DRAG THE FRAME TO SEE MORE DATA

SRRK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Scholar Rock Holding (SRRK) today?

A cotação de Scholar Rock Holding (SRRK) hoje está em US$ 56.51, com uma variação de 87.62% em relação ao último ano. A cotação de Scholar Rock Holding (SRRK) iniciou o ano negociando na casa dos US$ 44.05 e hoje está em US$ 56.51. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Scholar Rock Holding (SRRK) e dados de ações do Ibovespa e mercados internacionais.

Quando Scholar Rock Holding (SRRK) paga dividendos?

Scholar Rock Holding (SRRK) não distribuiu dividendos no último ano.

Is Scholar Rock Holding (SRRK) a good investment?

Atualmente, Scholar Rock Holding (SRRK) está cotada a US$ 56.51, com um P/L de -16.80, representando um desvio de -1,270% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 87.62 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 87.62%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Scholar Rock Holding (SRRK) stock?

Investir em ações de Scholar Rock Holding (SRRK) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Scholar Rock Holding (SRRK) yield today?

A rentabilidade de Scholar Rock Holding (SRRK) foi de 10.46% no último mês, 87.62% no último ano e 46.40% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Scholar Rock Holding (SRRK) hoje, o investimento total seria de US$ 5,651.00, com base na cotação atual de US$ 56.51.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 10,602.41
Em 5 anos: US$ 8,273.06
Em 10 anos: US$ 5,651.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SRRK

Scholar Rock Holding Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SRRK

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SRRK WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Scholar Rock Holding

Scholar Rock Holding Corporation

United States

9 years

2018

119

PROFIT X PRICE SRRK

Financial Results SRRK

SRRK cash flow

Asset, Revenue and Profit Growth - SRRK

SRRK balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions